Okonkwo DO, Shutter LA, Moore C, Temkin NR, Puccio AM, Madden CJ, et al
Molecular Metabolism 2019;30:72130
The FDA approval is based on the results from the DINAMO phase III trial, in which Jardiance was associated with a statistically significant reduction in the primary endpoint of change from baseline in A1c at 26 weeks compared with placebo in participants aged 10-17 years with type 2 diabetes
Two studies investigated animal models of comorbid depression and epilepsy 159,161 : one showed that exendin-4 led to an increase in frequency of absence seizures as well as depressogenic and anxiogenic responses 159 , while the other saw a decrease of depression-like behavior for liraglutide irrespective of concurrent use of the antiepileptic levetiracetam 161
The SIRT3/FOXO3 axis upregulates the PINK1/PARKIN axis to increase mitophagy when SIRT3 expression is increased 99
How Should GHK-Cu Pre-Mixed Cartridges Be Stored